Private
The Coalition for Epidemic Preparedness Innovations (CEPI) announced an additional $384 million investment into Novavax Inc. this week, as a means of accelerating development and manufacture of its NVX-CoV2373 COVID-19 vaccine candidate.
This extends ongoing collaboration between the two... Read More »
While many vaccine and treatment prospects have been put forward for dealing with COVID-19, health experts from the National Institutes of Health (NIH) have advised in a new Science-published paper that a collaborative strategy for testing, scale-up, and distribution of candidates is... Read More »
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for its COVID-19 laboratory developed test (LDT).
The action allows the testing of samples self-collected by patients at home using the Spectrum Solutions LLC... Read More »
Under a plan finalized on May 3, 607,000 vials of the drug remdesivir were donated for use in United States hospitals hosting COVID-19 patients by the drug’s creator, Gilead Sciences, Inc.
These shipments began to roll out on May 7, packed into cases and dispatched to Connecticut (30 cases),... Read More »
The United States’ preparedness and response capabilities have buckled under the stress of the ongoing COVID-19 pandemic and proactive work is needed to meet the next infectious disease before it strikes, said experts during the Bipartisan Commission on Biodefense May 8 virtual... Read More »
Industrial technology firm FLIR Systems has secured a $20.6 million Army contract to deliver Black Hornet 3 Personal Reconnaissance Systems in support of surveillance capabilities.
“Black Hornet has proven to be a game-changing technology – a small package that can deliver a big edge on the... Read More »
Researchers at the Lawrence Livermore National Laboratory (LLNL) have developed smart, breathable fabric designed to protect against biological and chemical warfare agents.
The material could be used by healthcare workers and first responders in clinical and medical settings as well as military... Read More »
Representatives from private industry and the federal government have joined forces to combat fraud and other illegal activity surrounding the COVID-19 pandemic.
The U.S. Homeland Security Investigations National Intellectual Property Rights Coordination Center (IPR Center) is working with... Read More »
A report from the independent, nonpartisan policy institute Center for American Progress (CAP) maintains the proposed fiscal year 2021 defense budget should more than adequately offer national security protections.
CAP officials said the analysis offers eight reasons why the $740 billion defense... Read More »
Beginning October 2020, the U.S. government will benefit from an additional 26 million N95 medical-grade masks per month, as part of a new deal struck between the Department of Defense (DoD) and 3M.
The $126 million contract was funded through the CARES Act, which was passed by Congress and... Read More »
Siemens Smart Infrastructure this week released the Siveillance Thermal Shield, a product capable of rapid, contactless temperature measurement at building entry points, as a means of adding potential illness tracking to general security.
The package consists of thermal imaging cameras capable... Read More »
Researchers at Johns Hopkins Bloomberg School of Public Health expect to shortly begin two trials of convalescent plasma – plasma taken from recovered COVID-19 patients – next week, with an eye on reducing hospital strain and helping both high-risk populations and those getting sick at... Read More »
Clinical trials on four potential vaccine candidates to prevent infection with the virus that causes COVID-19 disease.
The first U.S. patients have been dosed in a clinical trial conducted by Pfizer and BioNTech. They are being held at the NYU Grossman School of Medicine and the University of... Read More »
The search for potential COVID-19 vaccines continues, and the Coalition for Epidemic Preparedness Innovations (CEPI) has issued a call for proposals that could put funds in the hands of organizations with plans to boost development, manufacturing and geographic reach of vaccine candidates.
The... Read More »
Northern Arizona University researchers have developed computer modeling systems designed to predict outcomes of the regional spread of the SARS-CoV-2 virus, which causes COVID-19.
The approach is being implemented across Coconino, Navajo, Apache, and Mohave counties in response to the Flagstaff... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is collaborating with the Mayo Clinic on an expanded access program that will get patients hospitalized with COVID-19 access to convalescent plasma.
Convalescent plasma’s use is built on the idea that those who recover from... Read More »
The first American participants in the Phase 1/2 clinical trial of the BNT162 vaccine program, created by Pfizer Inc. and BioNTech SE, have been dosed as the companies ramp up manufacturing capabilities to meet 2020/2021 capacity needs.
That vaccine is meant to treat COVID-19, the disease that... Read More »
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Roche for its Elecsys Anti-SARS-CoV-2, or COVID-19, antibody test.
The test is designed to help determine if a patient has been exposed to the virus and if the patient has developed antibodies against... Read More »
The U.S. Biomedical Advanced Research and Development Authority (BARDA) placed a new order under the contract awarded in 2017 to Bavarian Nordic for the manufacturing and supply of Jynneos, a smallpox and monkeypox vaccine.
The new award is for $202 million. It is in addition to the existing... Read More »
Global security and aerospace company Lockheed Martin has secured a $6.07 billion Army contract to produce Patriot Advanced Capability-3 (PAC-3) Missile Segment Enhancement (MSE) interceptors and associated equipment.
"This contract demonstrates our customer's continued confidence in our ability... Read More »
Thanks in part to another $1.3 million of funding granted by the Coalition for Epidemic Preparedness Innovations (CEPI), an agreement between INOVIO and Richter-Helm BioLogics will expand to support large-scale manufacturing of investigational COVID-19 vaccine INO-4800.
INOVIO originally made... Read More »
A group of organizations jointly released guidance concerning mosquito-based diseases.
The International Atomic Energy Agency (IAEA), the Food and Agriculture Organization of the United Nations (FAO), the Special Programme for Training and Research of Tropical Diseases (TDR) and the World Health... Read More »
Puritan Medical Products has been awarded a Department of Defense (DoD) contract to produce COVID-19 testing swabs.
“The Department of Defense will invest $75.5 million in Defense Production Act Title 3 funding to increase swab production by 20 million per month starting in May,” Lt. Col.... Read More »
The National Institutes of Health (NIH) recently launched the $1.5 billion Rapid Acceleration of Diagnostics (RADx) initiative, to infuse funding into innovative technologies aimed at speeding innovation, development, and commercialization of reliable COVID-19 tests.
Those technologies need... Read More »
Biotechnology companies Entos Pharmaceuticals and EpiVax, Inc. announced a partnership this week dedicated to the development of a pan-coronavirus DNA vaccine.
"We are excited to be working with the exceptional team at EpiVax, whose computational approach to optimizing vaccine design is second... Read More »
The Infectious Diseases Society of America (IDSA) has released a primer regarding SARS-CoV-2 serology antibody testing, as well as the research and policy questions the effort raises.
“As serological testing for SARS-CoV-2 advances, there are multiple issues that need to be addressed, from... Read More »
The Phase 3 SIMPLE trial of Gilead Sciences Inc’s antiviral drug remdesivir has reached its primary endpoint, supplying positive data that COVID-19 patients administered the drug early fared better than those treated later.
From 397 patients, the study revealed that 62 percent of patients... Read More »
The Cerus Corporation has created the INTERCEPT Blood System as a means to reduce pathogens in red blood cells, and now, the Biomedical Advanced Research and Development Authority (BARDA) is collaborating with it to test the system’s capabilities against SARS-CoV-2.
SARS-CoV-2 is the virus... Read More »
The Bipartisan Commission on Biodefense is poised to assist a national COVID-19 commission that would be created under legislation introduced earlier this month.
Specifically, recommendations and pandemic plans issued by the Bipartisan Commission on Biodefense would be reviewed and evaluated by... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) will invest $3.5 million in Clover Biopharmaceuticals Australia to develop a COVID-19 vaccine.
It is CEPIʻs ninth investment in a COVID-19 vaccine. The investments total $39.6 million.
This latest investment will support Clover... Read More »
Professional services and technology firm KBR has secured a $63.9 million Department of Defense (DoD) task order to develop interoperability solutions resulting in expanded military testing and training capabilities.
KBR’s scope of work on the DoD’s Test Resource Management Center (TRMC)... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) announced two partnerships this week in its ongoing fight against COVID-19: America’s Blood Centers, to help collect and distribute convalescent plasma, and InBios International, Inc. to hasten the development of serological... Read More »
Boeing recently completed another COVID-19 transport mission resulting in 1.5 million medical-grade face masks reaching healthcare professionals at Prisma Health in South Carolina.
The Boeing Dreamlifter delivered personal protective equipment (PPE) from Hong Kong in partnership with Prisma... Read More »
Northern Arizona University (NAU) researchers staffing the Pathogen and Microbiome Institute (PMI) have launched the COVID-19 Testing Service Center (CTSC) to grow the SARS-CoV-2 virus and test drugs against it.
"The COVID-19 pandemic is a crisis that requires the whole scientific community... Read More »
An Oxford University vaccine for COVID-19 funded by the Coalition for Epidemic Preparedness Innovations (CEPI) last month has officially advanced into Phase 1 testing, complete with human trials.
Known as ChAdOx1 nCoV-19, the candidate is the third CEPI-funded vaccine to enter Phase 1 trials.... Read More »
